$0.6561
0.011.72%
At close: -
$0.6880
0.034.86%
After Hours: 4:11 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for PAVmed (PAVM) was reported on February 22, 2021 for Q4 2020. The company provided earnings per share guidance in the range of $-0.12 to $-0.12, compared to the estimated EPS of $-0.11. Additionally, PAVmed forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.